Clinical Trials Logo

Clinical Trial Summary

This is an Observational Study of children under the age of 11 diagnosed with Cockayne Syndrome to assess the natural progression of Cockayne Syndrome disease, with special attention to hearing and physical changes in length or height, weight, head circumference, and arm span during standard treatment.

The primary analytical objective is to determine the rate of linear growth over a 6-month period in children < 2 years of age and over a 12-month period in children ≥ 2 years of age.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort


Related Conditions & MeSH terms


NCT number NCT00985413
Study type Observational
Source DNage B.V.
Contact
Status Terminated
Phase N/A
Start date September 2009
Completion date February 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05484570 - Natural History Study for DNA Repair Disorders
Active, not recruiting NCT00001813 - Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Completed NCT01142154 - Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome Phase 1/Phase 2
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Active, not recruiting NCT02699190 - LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Recruiting NCT03047369 - The Myelin Disorders Biorepository Project
Recruiting NCT03044210 - Metabolic Study of Cockayne Syndrome N/A